News
Novo Nordisk, the maker of Ozempic and Wegovy weight-loss drugs, just regained the title as Europe’s most valuable company ...
Drugmaker Novo Nordisk is once again Europe's largest company by market capitalisation, rising above German software firm SAP ...
Wegovy maker Novo Nordisk is moving its investigational amycretin asset into late-stage weight loss trials starting early ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results